TR200003377T2 - Estrojenler ile bütünleşik 2-fenil-1-[4-(2-aminoetoksi)benzil]-indol - Google Patents

Estrojenler ile bütünleşik 2-fenil-1-[4-(2-aminoetoksi)benzil]-indol

Info

Publication number
TR200003377T2
TR200003377T2 TR2000/03377T TR200003377T TR200003377T2 TR 200003377 T2 TR200003377 T2 TR 200003377T2 TR 2000/03377 T TR2000/03377 T TR 2000/03377T TR 200003377 T TR200003377 T TR 200003377T TR 200003377 T2 TR200003377 T2 TR 200003377T2
Authority
TR
Turkey
Prior art keywords
aminoethoxy
estrogens
benzyl
phenyl
indole
Prior art date
Application number
TR2000/03377T
Other languages
English (en)
Turkish (tr)
Inventor
Harrison Pickar James
Samuel Komm Barry
Original Assignee
American Home Products Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22151320&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200003377(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by American Home Products Corporation filed Critical American Home Products Corporation
Publication of TR200003377T2 publication Critical patent/TR200003377T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
TR2000/03377T 1998-05-15 1999-05-11 Estrojenler ile bütünleşik 2-fenil-1-[4-(2-aminoetoksi)benzil]-indol TR200003377T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7956198A 1998-05-15 1998-05-15

Publications (1)

Publication Number Publication Date
TR200003377T2 true TR200003377T2 (tr) 2001-03-21

Family

ID=22151320

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03377T TR200003377T2 (tr) 1998-05-15 1999-05-11 Estrojenler ile bütünleşik 2-fenil-1-[4-(2-aminoetoksi)benzil]-indol

Country Status (41)

Country Link
EP (1) EP1076558B1 (enExample)
JP (3) JP2002515431A (enExample)
KR (1) KR100620772B1 (enExample)
CN (1) CN1230163C (enExample)
AP (1) AP1424A (enExample)
AR (1) AR020074A1 (enExample)
AT (1) ATE245026T1 (enExample)
AU (1) AU760378B2 (enExample)
BE (1) BE2015C026I2 (enExample)
BG (1) BG64783B1 (enExample)
BR (1) BR9911040A (enExample)
CA (1) CA2329530A1 (enExample)
CU (1) CU23241B7 (enExample)
CY (1) CY2015020I1 (enExample)
CZ (1) CZ299334B6 (enExample)
DE (1) DE69909616T2 (enExample)
DK (1) DK1076558T3 (enExample)
EA (1) EA005932B1 (enExample)
EE (1) EE04262B1 (enExample)
ES (1) ES2203131T3 (enExample)
FR (1) FR15C0035I2 (enExample)
GE (1) GEP20033079B (enExample)
HR (1) HRP20000778B1 (enExample)
HU (2) HU226587B1 (enExample)
ID (1) ID26890A (enExample)
IL (1) IL139130A (enExample)
IN (1) IN192220B (enExample)
LT (1) LTC1076558I2 (enExample)
LU (1) LU92699I2 (enExample)
NO (2) NO328129B1 (enExample)
NZ (1) NZ508200A (enExample)
OA (1) OA11552A (enExample)
PL (1) PL194750B1 (enExample)
PT (1) PT1076558E (enExample)
SI (1) SI1076558T1 (enExample)
SK (1) SK284666B6 (enExample)
TR (1) TR200003377T2 (enExample)
TW (1) TW565554B (enExample)
UA (1) UA66861C2 (enExample)
WO (1) WO1999059581A1 (enExample)
ZA (1) ZA200006959B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP1424A (en) * 1998-05-15 2005-06-06 Wyeth Corp 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens.
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
HU230543B1 (hu) 1999-07-06 2016-11-28 Endorecherche, Inc. Inzulinrezisztencia kezelésére és/vagy megakadályozására szolgáló gyógyszerkészítmények
US20020013327A1 (en) * 2000-04-18 2002-01-31 Lee Andrew G. Compositions and methods for treating female sexual dysfunction
WO2002003977A2 (en) * 2000-07-06 2002-01-17 Wyeth Combinations of statins, estrogenic agents and optionally estrogens
AU2001271784A1 (en) * 2000-07-06 2002-01-21 Wyeth Therapy for prosthesis-related bone degeneration
US6455568B2 (en) 2000-07-06 2002-09-24 Wyeth Combination therapy for inhibiting sphincter incontinence
CA2415052A1 (en) * 2000-07-06 2002-01-17 Wyeth Combinations of bisphosphonates, estrogenic agents and optionally estrogens
WO2002003989A2 (en) * 2000-07-06 2002-01-17 Wyeth Use of substituted indole compounds for treating sphincter incontinence
US6376486B1 (en) 2000-07-06 2002-04-23 American Home Products Corporation Methods of inhibiting sphincter incontinence
DE10117441A1 (de) * 2001-04-03 2002-10-10 Schering Ag 1-Indolylderivate, deren Verwendung zur Herstellung von Arzneimitteln, ein Verfahren zur Herstellung der 1-Indolylderivate sowie 1-Indolylderivate enthaltende pharmzeutische Präparate
EP1411922A1 (en) 2001-07-31 2004-04-28 Pfizer Products Inc. Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins
KR100470274B1 (ko) 2002-11-08 2005-02-05 진 장 덮개층을 이용한 비정질 물질의 상 변화 방법
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
FR2880625B1 (fr) * 2005-01-07 2007-03-09 Sanofi Aventis Sa Derives de n-(heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
BRPI0910656A2 (pt) 2008-04-16 2019-09-24 Karobio Ab ´´compostos ligantes de receptor de estrogênio, uso dos mesmos e composição farmacéutica´´
AR072297A1 (es) * 2008-06-27 2010-08-18 Novartis Ag Derivados de indol-2-il-piridin-3-ilo, composicion farmaceutica que los comprende y su uso en medicamentos para el tratamiento de enfermedades mediadas por la sintasa aldosterona.
GB201113538D0 (en) 2011-08-04 2011-09-21 Karobio Ab Novel estrogen receptor ligands
CN102690225B (zh) * 2012-04-11 2014-12-24 南京友杰医药科技有限公司 巴多昔芬的合成方法
CN103709090A (zh) * 2014-01-16 2014-04-09 江苏万特制药有限公司 醋酸巴多昔芬的制备方法及其关键中间体
CN103739540B (zh) * 2014-01-20 2016-05-04 华润赛科药业有限责任公司 一种醋酸巴多昔芬中间体的制备方法
CN105669518B (zh) * 2014-12-04 2019-06-04 上海医药集团股份有限公司 醋酸巴多昔芬及其a晶型的制备方法
CN111527080B (zh) 2017-12-15 2023-09-22 百时美施贵宝公司 取代的吲哚醚化合物
IT201800006562A1 (it) * 2018-06-21 2019-12-21 Procedimento e intermedi utili per la preparazione di indoli
US20230158152A1 (en) * 2020-03-17 2023-05-25 Medshine Discovery Inc. Proteolysis regulator and method for using same

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4729999A (en) * 1984-10-12 1988-03-08 Bcm Technologies Antiestrogen therapy for symptoms of estrogen deficiency
KR950701317A (ko) * 1992-05-08 1995-03-23 오오쓰까 아끼히꼬 인돌 유도체(Indole Derivative)
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
GB9326332D0 (en) * 1993-12-23 1994-02-23 Karo Bio Indole derivatives
DE4426625A1 (de) * 1994-07-27 1996-03-14 Schering Ag 2-Phenylindole, Verfahren zu deren Herstellung, diese enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
TW397821B (en) * 1996-04-19 2000-07-11 American Home Produits Corp 3-[4-(2-phenyl-indole-1-ylmethyl)-phenyl]-acrylamides and 2-phenyl-1-[4-(amino-1-yl-alk-1-ynyl)-benzyl]-1H-indol-5-ol as well as pharmaceutical compositions of estrogenic agents thereof
ATE206701T1 (de) * 1996-04-19 2001-10-15 American Home Prod Östrogene verbindungen
ATE277037T1 (de) * 1996-07-09 2004-10-15 Nikem Research Srl Indolderivate zur behandlung von osteoporose
US5672609A (en) * 1996-07-18 1997-09-30 Eli Lilly And Company Pyridine compounds, intermediates compositions and methods of use
CA2306343C (en) * 1997-10-15 2010-08-03 American Home Products Corporation Novel aryloxy-alkyl-dialkylamines
EP1049472A4 (en) * 1997-10-28 2002-04-03 Merck & Co Inc GONADOTROPIN RELEASING HORMON ANTAGONISTS
UA68365C2 (en) * 1997-11-06 2004-08-16 Wyeth Corp Peroral contraception by combination of anti-estrogen and progestin
AP1424A (en) * 1998-05-15 2005-06-06 Wyeth Corp 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens.

Also Published As

Publication number Publication date
HUP0103096A3 (en) 2002-11-28
HUP0103096A2 (hu) 2002-05-29
AU3894499A (en) 1999-12-06
DE69909616D1 (de) 2003-08-21
JP2014159472A (ja) 2014-09-04
DK1076558T3 (da) 2003-11-03
GEP20033079B (en) 2003-10-27
ZA200006959B (en) 2001-11-27
KR20010043641A (ko) 2001-05-25
BG64783B1 (bg) 2006-04-28
ATE245026T1 (de) 2003-08-15
AP2000001970A0 (en) 2000-12-31
PT1076558E (pt) 2003-11-28
EP1076558B1 (en) 2003-07-16
DE69909616T2 (de) 2004-06-17
NO20005770D0 (no) 2000-11-14
BR9911040A (pt) 2001-02-13
EP1076558A1 (en) 2001-02-21
NO2015015I1 (no) 2015-06-02
JP2002515431A (ja) 2002-05-28
ID26890A (id) 2001-02-15
IN192220B (enExample) 2004-03-20
OA11552A (en) 2004-06-07
BE2015C026I2 (en) 2018-08-24
CU23241B7 (es) 2007-10-17
PL345268A1 (en) 2001-12-03
IL139130A0 (en) 2001-11-25
EE200000652A (et) 2002-04-15
HRP20000778B1 (en) 2004-10-31
FR15C0035I2 (fr) 2015-08-28
AR020074A1 (es) 2002-04-10
KR100620772B1 (ko) 2006-09-13
UA66861C2 (uk) 2004-06-15
FR15C0035I1 (enExample) 2015-06-26
EA005932B1 (ru) 2005-08-25
HUS1500023I1 (hu) 2017-03-28
NZ508200A (en) 2003-09-26
HU226587B1 (en) 2009-04-28
SK17202000A3 (sk) 2001-07-10
LTC1076558I2 (lt) 2016-11-10
WO1999059581A1 (en) 1999-11-25
JP5872624B2 (ja) 2016-03-01
EE04262B1 (et) 2004-04-15
JP2009019042A (ja) 2009-01-29
SK284666B6 (sk) 2005-08-04
HK1031691A1 (en) 2001-06-22
AU760378B2 (en) 2003-05-15
NO20005770L (no) 2001-01-12
HRP20000778A2 (en) 2001-06-30
NO328129B1 (no) 2009-12-14
TW565554B (en) 2003-12-11
CZ20004254A3 (cs) 2001-12-12
JP5607871B2 (ja) 2014-10-15
LU92699I2 (fr) 2015-06-24
SI1076558T1 (en) 2003-10-31
NO2015015I2 (no) 2015-06-02
ES2203131T3 (es) 2004-04-01
PL194750B1 (pl) 2007-06-29
CY2015020I1 (el) 2020-05-29
CN1326347A (zh) 2001-12-12
CZ299334B6 (cs) 2008-06-25
AP1424A (en) 2005-06-06
EA200001193A1 (ru) 2001-12-24
IL139130A (en) 2005-11-20
CN1230163C (zh) 2005-12-07
CA2329530A1 (en) 1999-11-25
BG104930A (en) 2001-07-31

Similar Documents

Publication Publication Date Title
TR200003377T2 (tr) Estrojenler ile bütünleşik 2-fenil-1-[4-(2-aminoetoksi)benzil]-indol
TR200102800T2 (tr) Yeni bileşikler.
TR200101815T2 (tr) Sulu reaktif dolgu bileşimleri (I).
PT998460E (pt) Novos derivados de tetrazole
BR9707233A (pt) Fenantridinas
ATE228502T1 (de) Substituierte analoge von indol-3-carbinol und von diindolmethan als antiestrogene
TR200001218T2 (tr) İkameli karboksamidotiazoller, bunların üretimi ve bunları içeren farmasötik bileşimler.
DK0889886T5 (da) Hidtil ukendte, i 6-stilling substituerede phenanthridiner
TR199801679T2 (xx) Osteoporoz i�in birle�tirme terapisi.
BR9806752A (pt) Ftalazinonas.
YU19499A (sh) Benzonaftiridini kao bronhijalni terapeutici
AR010062A1 (es) Nuevos benzamidaldehidos y su utilizacion
TR199801255T2 (xx) Vitronektin resept�r antagonistleri.
SE9702773D0 (sv) Novel compounds
TR200000152T2 (tr) Yeni bileşikler.
TR200002896T2 (tr) Kalsilitik Bileşimler
ATE318810T1 (de) 3-oxadiazol-5-yl-1-aminoalkyl-1h-indolderivate
TR200102041T2 (tr) Progesteron reseptör bağlama aktif maddeleri olarak ikameli 2-arilimino heterosaykıllar
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
TR200101979T2 (tr) Antidepresyon tedavisi için 5HT1 antagonistleri.
DK1204659T3 (da) Serotonerge benzofuraner
ATE320422T1 (de) Metalloproteinase inhibitoren
BR9713176A (pt) Benzotiofenos amorfos,métodos de preparação e métodos de uso
TR199800152T1 (xx) Endotelin Resept�r Antagonistleri
TR200101030T2 (tr) İnsanlara özgü NK3 reseptörlerinin seçici antagonistleri olarak üreidopiperidin türevleri